Hassman Research Institute | Marlton, NJ
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Hassman Research Institute
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
This study is designed to test the weight loss effects, safety, and tolerability of multiple monthly doses of MET097 after 12 weekly doses, compared...
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized A...
The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type...
Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia
This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related...
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabet...
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated...
Trial sponsors
Clinical trials
Research sites
Resources
Legal